• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


6.909 EUR 0.287 3.99%

As of 04:55:02 ET on 09/16/2014.

Snapshot for Verastem Inc (2VS)

Open: 6.840 Day's Range: 6.840 - 6.909 Volume: 0
Previous Close: 7.196 52wk Range: 5.056 - 12.058 1-Yr Rtn: -35.85%

Stock Chart for 2VS

No chart data available.
  • 2VS:GR 6.909
  • 1D
  • 1M
  • 1Y
Interactive 2VS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 2VS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -2.0440
Est. PEG Ratio -
Market Cap (M EUR) 178.54
Shares Outstanding (M) 25.84
30 Day Average Volume 113
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 2VS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 2VS

Verastem Inc., is a clinical biopharmaceutical company. The Company focuses on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Verastem also develops proprietary companion diagnostics for stem cells. The Company's technology allows the creation of stable programs for various signaling pathways.

Christoph H WestphalChairman/Co-FounderRobert ForresterPresident/CEO
John B Green "Jack"Chief Financial OfficerDaniel PatersonChief Business Officer
More Company Profile & Key Executives for 2VS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil